Insmed Inc. buy Wells Fargo & Company
Start price
23.03.26
/
50%
€126.00
Target price
23.03.27
€151.55
Performance (%)
-35.09%
Price
05.06.26
€89.19
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Insmed Inc. is performing very badly with a performance of -35.09%. This prediction currently runs until 23.03.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.439% | -2.439% |
| iShares Core DAX® | -1.862% | 0.670% |
| iShares Nasdaq 100 | -3.322% | 4.989% |
| iShares Nikkei 225® | -2.299% | 6.129% |
| iShares S&P 500 | -1.313% | 3.399% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) had its price target lowered by Wells Fargo & Company from $208.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat